NEW YORK, May 24 (GenomeWeb News) - GeneGo has received a Phase I SBIR grant from the National Institute of Environmental Health Sciences to analyze cellular signaling networks activated in response to drugs and toxins, the St. Joseph, Mich.-based company said today.
The company did not list the amount of the grant, but according to an NIH database, GeneGo received a $98,648 grant from NIEHS this month for a 6-month project, entitled "Networks From Toxicogenomics Gene Expression Data."
In the first phase of the project, GeneGo will reanalyze publicly available data using its MetaCore platform.